Skip to content
Search
EN

Monash Study: Low-Dose Aspirin Cuts Dementia Risk by 70%

Low-dose aspirin may benefit older adults with certain genetic profiles, but bleeding risk requires attention.

Monash Study: Low-Dose Aspirin Cuts Dementia Risk by 70%
Mediaindonesia
Verified Source

Mediaindonesia

View Original Report
1 min readRead in Indonesian

Older adults with certain genetic profiles may reduce dementia risk by up to 70 percent through low-dose aspirin use, according to the latest Monash University study, which also records bleeding risk as a side effect.

Dementia is a progressive cognitive disorder common among older adults, while low-dose aspirin has long been known as a blood thinner. These findings show aspirin response can be influenced by genetic factors, so its benefits are not universal across the entire older adult population.

However, the study also emphasizes bleeding risk accompanying low-dose aspirin use. This condition highlights the importance of medical consultation before administering aspirin, especially to older adults with certain genetic profiles.

Topics

AspirinDemensiaMonash UniversityPendarahan